LogiPharma Asia 2025 Blog

This guide, informed by the insights of Jon Chapman, Global Vice President, Healthcare Services at Kuehne+Nagel, explores key change management tactics to ensure a smooth and successful adoption process. Imagine a system that keeps customers informed on the distribution and stock of vital medical supplies, powered by AI's ability to manage inventory, optimize transportation routes, and provide end-to-end visibility.

This infographic contributed by AruneGanesh Meenakshisundaram, Supply Chain Director, ex P&G, explores key strategies to balance cost-efficiency, adaptability, and resilience for any organisation. We understand a one-size-fits-all solution doesn't work. Every company has unique strategic goals, risk tolerances, and sustainability practices – all while keeping an eye on costs. This guide will help you tailor your approach to supercharge your response to disruptions, without sacrificing long-term value.  

In this exclusive Q&A interview, Volker Cloos, Director Global Logistics and Supply Chain Asia, Eli Lilly and Company and Brett Marshall, Vice President – Quality & HSSE, Zuellig Pharma unravel their insights on the importance of performing risk mitigation.

The traditional focus on cost-cutting for procurement can clash with the growing importance of sustainability. This interview seeks to shed light on how to bridge that gap.

 In this exclusive Q&A interview, Arune Ganesh Meenakshisundaram, Gaurav Bhatia, General Manager of Supply Chain from Reliance Retail Pharma, Bharath Sundararaman, Vice President & General Manager of Supply Network Optimisation from Tracelink, and Gordon Willcock, Director from Asia Pacific Direct Relief, share their insights on data aggregation, supplier collaboration, and the role of technology in predicting excursions in temperature. 

In this exclusive Q&A interview, Swapna Shetye, Regional Procurement Manager APAC from Bayer, and Jon Chapman, Global Vice President of Health Services in Kuehne Nagel, share their insights on assessing supplier performance, striking the right balance between sustainability and costs, and moving away from using non-biodegradables like plastics. 

Building a strategic workforce requires a re-imagining of what the pharmaceutical and healthcare sector looks like. Yulia Celeteria, Head of Logistics from EarlyHealthGroup, Frank Binder, Corporate Officer & Global Head of Supply Chain Management from Santen, and Yingming Yue, VP of Operations and Supply Chain APAC from Lotus Pharmaceutical, share their insights on strengthening employees' value and fortifying a culture of continuous growth through training and individual development programmes. 

Brett Marshall, Vice President of Quality & HSSE from Zuellig Pharma, Gaurav Bhatia, General Manager Supply Chain from Reliance Retail Pharma, Volker Cloos, Director Global Logistics and Supply Chain Asia from Eli Lilly and Company, and Tam C. Nguyen, Deputy Director of Research from St Vincent’s Hospital Melbourne, share their insights on the ever-increasing role of AI and Machine Learning and the striking differences between the Fast Moving Consumer Goods (FMCG) industry and the pharmaceutical one. 

Ramesh Raj Kishore, Regional Director of Pharmaceutical Security Institute (PSI) in Asia Pacific, unpacks the topic by sharing that the focus lies on proactive measures: embracing cutting-edge technologies, fostering close ties with governing bodies and international organisations.

In our latest exclusive video interview with Suhail Ali from ICON PLC, we explore challenges and strategies in drug delivery logistics with a focus on the extremely fragmented APAC region. Find out from Suhail how companies are meticulously staying updated with regulatory requirements, ensuring that there’s minimal to no disruptions in the delivery.

What can firms do to counteract against the impending forces in the growing yet uncertain healthcare market? As the Head of Extended Supply Chain and Operational Excellence at FarmaMondo SA, Dario Bisogni shares his intriguing insights on how to maintain stringent Quality Assurance (QA) standards whilst facing unforeseen challenges. By leveraging on state-of-the-art technologies such as AI and blockchain, and strategic measures, he is able to enhance end-to-end visibility and trace every product at respective stages of its lifecycle.

In the past, the commercial and supply chain functions have operated in silos, hindering their ability to work towards a common and unified goal. This thought leadership article explores the power of breaking down these siloes, bridging the gap and fostering collaboration between these teams.

Chee Yong Ng shares his insights on the sales funnel strategy, whereby emerging prospects are dependent on customers’ confidence level and their behaviour that guide every decision they make. It will help them to strike a balance when resolving supply and demand issues alongside aligning those numbers with internal growth targets, avoiding risks tied to compromised run rates.

“Health is wealth” was the key global takeaway from the pandemic. It highlighted how critical the pharmaceutical supply chain was and still is - to ensure the prompt and proper delivery of medical products. However, it also exposed gaps made more prominent over the pre-pandemic years.

This article entails some of the critical challenges faced by pharmaceutical supply chains involved in Asia and strategic insights on how to tackle these challenges. Let’s get unpacking!

As pharma leaders, transitioning to proactive, resilient strategies is no longer an option but a necessity. What happens when the next world crisis hits? What happens if we have a COVID 2.0, war breaks out, or an economy upends without warning?

Modern businesses must move beyond crisis-driven responses to establish supply chains designed not just to cope with sudden disruptions that may surface but thrive within an ever-changing and uncertain terrain.

This guide will explore actionable and future-proof strategies to execute pharma supply chain management and ensure preparedness in the event of another global challenge.

You are no stronger than your weakest link. We invited Robert Paterson, Regional Commercial Manager - APAC - Tower Cold Chain, Mitchell Coats, General Manager Pharma Vertical, EFL Global - India, Tsu Rasolonjatovo, Global Logistics Transformation Leader & Global Process Owner, Elanco, and Dr Arani Chatterjee to give us their thoughts of what constitutes a successful partnership: the importance they have to the business, what makes each partnership exceptional and what criteria you must use to access their value.

We hear how “pharma companies are always seeking a single version of truth” - and their perspectives on the benefits real-time visibility brings - whether that’s allowing you to consolidate information from various supplier sources to know exactly what is happening and when or improving partner relationships. Listen as our speakers describe why a lot of scenario planning must be incorporated into the supply chain if you’re looking to improve resilience and risk mitigation strategies.

When we talk about digital transformation - what do we mean? Digital transformation means something to everyone, it’s subjective and specific to the needs of your business. We invited Derek Less, VP Pharma & Healthcare, APAC JAS Worldwide, Christoph Bamert, Global Head of Sales & marketing, MD APAC ELPRO, Chris Edwards, Senior Vice President - Asia Pacific One Network Enterprises and Gaurav Bhatia, General Manager Reliance Retail, to talk to us about what digital transformation means to them - what drives the decisions, the partnerships, the investment decisions and ultimately delights the customer.

In this exclusive interview, we invited Ana Martinez Lozano, Assistant Director Distribution & Logistics Quality EMEA Lead at MSD, Marco Gaudesi, Head of GSDP & Cold Chain at MSF (Doctors without Borders), and Henri Lee, Group Managing Director at Aeris Dynamics to give us insights on the latest technology to better improve a temperature sensitive and controlled shipment, tips on how common challenges in this area can be mitigated, and other precautions that needs to be considered when transporting medicine such as counterfeit goods and security.

In this exclusive interview, we brought Yang Yan, Sales Manager at Beijing CIMC Lengyun Technology Co., Ltd, Wallace Tay, Managing Director at va-Q-tec Singapore, Patrick Blain, Global Sales Director at Emball’iso, Prathyusha Parakala, Program Manager for Sustainability at Dr Reddy’s Laboratories, and Remi Cesaro, Founder & Executive Director at Zero Waste City together to share about their thoughts on this topic, including how much attention should be paid in creating sustainable supply chains in your company (and how important it is for leadership to have the vision for the long-term thinking of how sustainability matters), and the challenges faced.

For this exclusive interview, we spoke to Nikkita Johal, Assistant Director - Global Compliance Monitoring at Gilead Sciences, Shawn Lim, Senior Supply Chain Manager at Santen Asia, Mohit Agarwal, Head of Emerging Markets - SFE at Sun Pharma, and Shirish Ambulgekar, Vice President - Corporate Quality at Sun Pharma about the struggles they’ve experienced in recruiting and retaining young and qualified talent. They also share about what the company has done to overcome the issue, such as using data-driven approaches when developing talent in the supply chain industry.

Ravinder Dhar, Director of Supply Chain - APAC Markets at Teva Pharma Australia shares with us the tips he has for large companies looking to drive transformation in their end-to-end supply chain. The supply chain process in pharma is extremely complicated as it’s highly regulated, and starting with a clear strategy is important to the transformation, knowing whether you’d like to build a supply chain that is customer-centric or cost-effective.

Join Fais Adha, Head of Supply Chain for Malaysian Healthcare provider - IE Direct as he talks to us about the unique challenges in Regulatory Compliance, Intellectual Property Protection and Collaboration & Trust in Pharma. Fais dives into supply chain bridging - what’s changed and why, why blockchain’s immutable record feature is beneficial in Pharma and how tech trends meet market needs.

In this quick-fire Q&A - Ana Martinez Lozano, Associate Director Distribution & Logistics Quality EMEA Lead, MSD, give us a window into the pharma giant MSD’s perspective on key concerns facing our industry today. We discuss the changes brought on by Ai & ML and how MSD has adapted their processes and tech to keep up. We talk Blockchain, obstacles as a big pharma player and obstacles when embedding new systems.

In this exclusive interview, Pratyusha Parakala, Program Manager, Sustainability at Dr Reddy's takes us through her journey to Antarctica and the reason she felt compelled to get closer to the planet to drive sustainability and raise awareness for the causes she supports. She highlights the importance of each person taking the extra step to practice sustainability and the various campaigns she has focused around.

Watch the interview now

Tam Nguyen is a respected voice in the Medtech and Health Tech start-ups community. With over 20 years of experience in clinical trials, health and medical research and having pioneered innovation and advancement in the healthcare sector for many years, Tam joined us for an exclusive interview ahead of LogiPharma Asia.

Successful collaborations can speed up market access and fast-track authorisation to access local markets in different countries. In this article, we explore key strategies and pitfalls to avoid when building a successful pharmaceutical partnership.

Diversification and inclusion are no strangers in pharma. Life science companies today continue to strive to change the narrative of the lack of women taking on leadership roles that would expand their scope of capabilities, directing the new wave of millennial talent in the workforce toward sustainable change in both the public and private sectors. In this blog, we tackle challenges facing pharma companies to find out how to bridge gender & cultural gaps.

Indeed, there is much to be gained through sharing knowledge and experience. In this article, we discuss how pharma can look to innovative solutions being adopted in other industries to discover where technologies and strategies can help industry progression, bringing pharma up to speed in dealing with the demands of today.